Closed cell systems is pleased to announce that it has obtained a license agreement for the development and commercialisation of a new point of care cell processing system. This closed system will automatically thaw a frozen vial, wash the cell suspension removing cryopreservative, concentrate and fill a syringe. The automated process will take approximately 30min to deliver a single patient dose ready for administration together with a batch manufacturing record.
During the next 2 years, the equipment will be exhaustively tested at an independent cell therapy facility in the UK. In parallel, the equipment will be production engineered and the supply chain put into place. The picture shows the benchtop prototype.
For further details and to discuss evaluations and collaborations, please contact info@closedcellsystems.com